Has participated in:
-
Morphological and functional characterization of persistent DNA-damage foci
-
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
-
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition
-
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma